Healthcare
Pancreatic Amylase Reagent Market

Pancreatic Amylase Reagent Market

Pancreatic Amylase Reagent Market - Global Industry Analysis 2014 - 2018 and Forecast 2019 - 2029

ID: PMRREP30651

Upcoming

Introduction

Pancreatic amylase is the enzyme produced in the pancreatic tissue, which helps in the digestion of starch from the ingested food. Pancreatic amylase reagent assay performed for the quantitative determination of pancreatic amylase in the plasma and serum. This pancreatic amylase reagent assay based upon the colorimetric method.

Normally pancreatic amylase reagent used to diagnose the acute and chronic pancreatitis. Pancreatic amylase reagent also used to diagnose the perforated ulcers, gall bladder diseases, mumps or ectopic pregnancy. Pancreatic amylase reagent used to activate the two monoclonal antibodies in the serum or plasma, this activates antibodies increases the light absorbance of the sample.

The absorbed light wavelength help to identify the pancreatic amylase in the sample. Normal pancreatic amylase level in the body ranges from 19 units per liter (U/L) and 86 U/L., however, the proper pancreatic amylase regent should be used during the test to achieve the good result.

Pancreatic amylase regent kit includes Sodium phosphate, monobasic buffer, Sodium chloride, Starch from potato, Sodium hydroxide, Potassium sodium tartrate, 3,5-Dinitrosalicylic acid.

Rising patient pool suffering from the acute and chronic pancreatic disorders may drive the pancreatic amylase reagent market. People suffering from the disorders like indigestion, gastroesophageal reflux disease (GERD) may show the fueling growth for pancreatic amylase reagent market.

Disease conditions like persistent diarrhea, vitamin deficiency, malnutrition will show the additional demand of the pancreatic amylase reagent market. In children cystic fibrosis (CF) or Shwachman-Diamond Syndrome (SDS) diagnosis may show the propelling growth for pancreatic amylase reagent market.

Alternative diagnosis methods like CT scan, Endoscopy for the pancreatic testing may show the slower growth for pancreatic amylase reagent market. Awareness of the people about the cystic fibrosis and pancreatic cancer may show the stagnancy in the pancreatic amylase reagent market.